C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators. - Test2 - elhamkhani - TriplyDB

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

http://www.wikidata.org/entity/Q34699045

about

Investigational insulin secretagogues for type 2 diabetes.Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394.

P2860

Q38735419-CE5DB760-4DC3-433F-A32A-25DA53887712 Q41763826-A4F9C1C2-F3BD-41D4-8129-7C7DEDC54DAD

P2860

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

http://www.wikidata.org/entity/Q34699045

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@ast

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@en

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@nl

type

label

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@ast

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@en

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@nl

prefLabel

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@ast

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@en

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@nl

P1433

Q34699045-5F5D8E1A-4495-4052-8A24-879DFE2570BC

P1476

Q34699045-69A10CE8-5463-4EB0-9587-EDB9093E2174

P2093

Q34699045-0213A88E-CC12-43A2-9885-D1091643C5EE

Q34699045-06BE79A0-CCE3-4DB0-8A1E-BE4536E978EF

Q34699045-29E5C880-3EBE-40BC-918E-6AA7258CA078

Q34699045-399AAA2D-E221-4AA0-A145-A3E22D2A2D8A

Q34699045-3D5F8597-5080-4EDB-BD85-69CBE4CD0445

Q34699045-3E892CB5-020E-472C-B47F-FD92712B3888

Q34699045-40226E49-3FE3-411D-89B1-CAEBF685326D

Q34699045-44C6AFDB-9F64-4A25-9C99-D9A088DD7B58

Q34699045-496C0778-4984-4181-A562-502766B13A61

Q34699045-4FBC2224-4279-4BF8-8506-D2168B23ED81

P2860

Q34699045-1D880EBC-38EF-4E7D-9062-D17281A44A02

Q34699045-2A6680F2-C4C3-4720-BEA2-BB8B350374D1

Q34699045-2B893AEE-D950-450B-B443-544F1DDC01AD

Q34699045-3A63257C-DE93-451D-A8B7-0A5063BBA3EB

Q34699045-4CA27448-2B82-4FD3-8AB5-5A8D6B4C7BD2

Q34699045-52E64885-8D13-4912-8FCB-C4960769FB7F

Q34699045-5586C819-1CE5-4AE5-B568-08EEE3071256

Q34699045-58EAA7CD-3D65-4991-83FC-539349247C88

Q34699045-5E48A4AA-89A5-476D-B60C-AC7DD0585A62

Q34699045-61BCD562-ACDE-41CB-A2C0-AD75C832AD43

P304

Q34699045-AC3B53F3-13F8-40AD-89DE-786507992945

P31

Q34699045-20959EEA-4D2E-4BAE-8957-F94B679B4F4E

P356

Q34699045-41246B0F-0B70-43E0-B565-EB7EAA4A97A1

P433

Q34699045-EC9D673E-4A88-4100-B1FE-B60AD36ED1F5

P478

Q34699045-7C7EDDE0-9B2B-49AF-BAB2-F9D324927E81

P577

Q34699045-D32936CC-D146-4B91-B5B6-3237872003E8

P698

Q34699045-A7B9AC3C-E672-491D-B56D-0DFFEBB3A277

P932

Q34699045-77929A4A-2CCD-4116-BBAB-26FBC1726462

P356

P1433

ACS Medicinal Chemistry Letters

P1476

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

@en

P2093

Bin Wang

http://www.w3.org/2001/XMLSchema#string

Brian R Baer

http://www.w3.org/2001/XMLSchema#string

David Chow

http://www.w3.org/2001/XMLSchema#string

Deborah A Anderson

http://www.w3.org/2001/XMLSchema#string

Jaehyeon Park

http://www.w3.org/2001/XMLSchema#string

Jasmine Davda

http://www.w3.org/2001/XMLSchema#string

Jerry Yang

http://www.w3.org/2001/XMLSchema#string

Jonathan B Houze

http://www.w3.org/2001/XMLSchema#string

Josef R Bencsik

http://www.w3.org/2001/XMLSchema#string

Julio C Medina

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular physiology of mammalian glucokinase

Identification of a new class of glucokinase activators through structure-based design

Discovery of 2-pyridylureas as glucokinase activators

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

Medicinal chemical properties of successful central nervous system drugs

Molecular properties that influence the oral bioavailability of drug candidates.

Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes

A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate.

Assessing the potential of glucokinase activators in diabetes therapy.

Characterization of a novel glucokinase activator in rat and mouse models

P304

1284-1289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML500341W

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25516785

http://www.w3.org/2001/XMLSchema#string

P932

4265826

http://www.w3.org/2001/XMLSchema#string